Prudential Financial
KYNB

Prudential Financial’s Kyntra Bio KYNB Stock Holding History

Prudential Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,208
Closed -$26.9K – 2735
2024
Q2 		$26.9K Sell
1,208
-232
-16% -$7.17K ﹤0.01% 2658
2024
Q1 		$84.6K Buy
1,440
+488
+51% +$21K ﹤0.01% 2544
2023
Q4 		$21.1K Hold
952
– – ﹤0.01% 2614
2023
Q3 		$20.5K Buy
+952
New +$37.4K ﹤0.01% 2570
2023
Q2 		– Sell
-9,297
Closed -$4.34M – 2646
2023
Q1 		$4.34M Buy
+9,297
New +$4.92M 0.01% 927
2021
Q4 		– Sell
-1,221
Closed -$312K – 2651
2021
Q3 		$312K Sell
1,221
-408
-25% -$145K ﹤0.01% 2299
2021
Q2 		$1.08M Sell
1,629
-82
-5% -$47.2K ﹤0.01% 1796
2021
Q1 		$1.49M Sell
1,711
-7,142
-81% -$7.6M ﹤0.01% 1624
2020
Q4 		$8.21M Sell
8,853
-1,431
-14% -$1.5M 0.01% 823
2020
Q3 		$10.6M Sell
10,284
-131
-1% -$141K 0.02% 631
2020
Q2 		$10.6M Sell
10,415
-3,195
-23% -$2.97M 0.02% 674
2020
Q1 		$11.8M Sell
13,610
-3,177
-19% -$3.16M 0.03% 575
2019
Q4 		$18M Sell
16,787
-1,488
-8% -$1.52M 0.03% 624
2019
Q3 		$16.9M Buy
18,275
+12,684
+227% +$13.9M 0.03% 606
2019
Q2 		$6.32M Buy
5,591
+2,928
+110% +$3.2M 0.01% 1045
2019
Q1 		$3.62M Sell
2,663
-1,190
-31% -$1.61M 0.01% 1283
2018
Q4 		$4.46M Sell
3,853
-1,571
-29% -$1.77M 0.01% 1140
2018
Q3 		$8.24M Sell
5,424
-8,230
-60% -$12.7M 0.01% 992
2018
Q2 		$21.4M Sell
13,654
-1,312
-9% -$1.71M 0.03% 590
2018
Q1 		$17.3M Buy
14,966
+3,293
+28% +$4.34M 0.03% 670
2017
Q4 		$13.8M Sell
11,673
-579
-5% -$726K 0.02% 794
2017
Q3 		$16.5M Sell
12,252
-5,699
-32% -$6.01M 0.02% 709
2017
Q2 		$14.5M Buy
17,951
+1,577
+10% +$1.1M 0.02% 742
2017
Q1 		$10.1M Buy
16,374
+7,987
+95% +$4.86M 0.02% 851
2016
Q4 		$4.49M Buy
8,387
+3,356
+67% +$1.68M 0.01% 1160
2016
Q3 		$2.6M Buy
5,031
+3,037
+152% +$1.43M ﹤0.01% 1379
2016
Q2 		$818K Buy
+1,994
New +$913K ﹤0.01% 1888

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Prudential Financial's KYNB Position: Q3 2024 in Review

Prudential Financial sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 1,208 shares — an estimated $26.9K sold.

Prudential Financial first reported a position in KYNB in Q2 2016 and held it in 27 quarters. The position peaked at $21.4M in Q2 2018. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Prudential Financial reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Prudential Financial sold 1,208 Kyntra Bio shares in Q3 2024, an estimated $26.9K.
  • Prudential Financial first reported a position in Kyntra Bio in Q2 2016 and held it in 27 quarters.
  • Prudential Financial's Kyntra Bio position peaked at $21.4M in Q2 2018.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Prudential Financial's 13F filing for Q3 2024, filed 14 Nov 2024.